AICD / Combo Device Implantation

An AICD Combo Device (Automated Implantable Cardioverter Defibrillator Combo Device) is a specialized medical device that combines the functionality of both a pacemaker and a defibrillator. It is implanted in patients at risk of life-threatening heart arrhythmias such as ventricular tachycardia or ventricular fibrillation. The AICD Combo device continuously monitors the heart’s rhythm and can deliver therapy to restore a normal rhythm if an abnormal rhythm is detected.

AICD Combo Device Implantation is generally recommended for individuals at high risk of life-threatening arrhythmias. The main causes that lead to implantation include:

Coronary Artery Disease (CAD): Narrowed or blocked coronary arteries can lead to reduced blood flow to the heart, which can cause arrhythmias or heart failure.

Heart Failure: Patients with weakened heart muscles (due to conditions like CAD, hypertension, or a previous heart attack) may be at risk of abnormal heart rhythms. Heart failure can also lead to an inability to effectively pump blood, prompting the need for pacing or defibrillation.

Previous Cardiac Arrest: If a patient has survived a sudden cardiac arrest (SCA), they are at an elevated risk of recurrence. An AICD Combo device can help prevent another occurrence.

Genetic Conditions: Inherited arrhythmia syndromes like Long QT Syndrome, Brugada Syndrome, or Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) may cause potentially fatal arrhythmias that can be managed with an AICD Combo device.

Post-Myocardial Infarction (Heart Attack): Following a heart attack, scar tissue can form in the heart muscle, potentially leading to arrhythmias. AICD Combo devices help prevent sudden cardiac arrest in these individuals.

Cardiomyopathy: This condition, which involves abnormal thickening or thinning of the heart muscle, can predispose individuals to arrhythmias and sudden cardiac arrest. The device can help regulate heart rhythm in these patients.